Actively Recruiting

Phase 4
Age: 19Years +
All Genders
NCT04499859

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

Led by Kiyuk Chang, MD,PhD · Updated on 2025-07-30

3548

Participants Needed

7

Research Sites

360 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Combination therapy of rosuvastatin 5mg and ezetimibe 10 mg showed similar achievement rate in decreasing LDL cholesterol level by 50% as single use of rosuvastatin 20 mg. This trial aims to prove non-inferiority of concomitant usage of low dose rosuvastatin and ezetimibe among patients with acute myocardial infarction who went through percutaneous coronary intervention at decreasing major adverse cardiac events compared to the efficacy of single use of high dose rosuvastatin.

CONDITIONS

Official Title

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 19 years and older
  • Diagnosed with myocardial infarction (both ST segment elevation and non-ST segment elevation) treated with percutaneous coronary intervention
  • Female patients of childbearing age who agree to mandatory pregnancy testing
  • Patients who have agreed to and signed the informed consent form
Not Eligible

You will not qualify if you...

  • Life expectancy of one year or less due to cancer
  • Chronic liver disease
  • Sensitivity to rosuvastatin or ezetimibe, or contraindications to these drugs
  • Pregnant or breastfeeding
  • Female patients unable to use contraception
  • Patients on hemodialysis, peritoneal dialysis, or with kidney transplant due to end stage renal disease
  • Participation in another clinical trial within 3 months before screening (except non-interventional observational studies)
  • Any other reasons deemed inappropriate for the study by the investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Bucheon St.Mary Hospital

Bucheon-si, Gyeonggido, South Korea

Actively Recruiting

2

St.Vincent's Hospital

Suwon, Gyeonggido, South Korea

Actively Recruiting

3

Uijeongbu St.Mary's Hospital

Uijeongbu-si, Gyeonggido, South Korea

Actively Recruiting

4

Daejeon St.Mary's Hospital

Daejeon, South Korea

Actively Recruiting

5

Incheon St.Mary's Hospital

Incheon, South Korea

Actively Recruiting

6

Seoul St.Mary's Hospital

Seoul, South Korea, 137-701

Actively Recruiting

7

Yeouido St.Mary Hospital

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

K

Kiyuk Chang, MD,PhD

CONTACT

E

Eun Ho Choo, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here